explore -WSS

explore

author：Wikipedia 2025-09-27 12:56:57 - browse：4127

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Drug repurposing or repositioning? The language matters
Next article： Dewpoint Therapeutics lays off staff after losing partnerships

explore

WSS

Readout Newsletter: Merck, J&J, and long Covid

Novartis develops a rapidly manufactured CAR

Novartis develops a rapidly manufactured CAR

Elizabeth Holmes banned from government health programs

Severe heat forecast: Where scorching temperatures will persist over the next week

4 missing after record

entertainment

explore

focus

DIEP, the 'gold standard' of breast reconstruction, is under threat

AI generated plenty of interest at JPM but not a lot of trust

Medical records are filled with copy

New brain studies show LSD's effects on the brain in full color

Peter Hotez and the public health issue of online harassment

Readout LOUD podcast: Biotech layoffs, stock slump, 2024 preview

23andMe had bad news about my health. I wish a person had delivered it

New brain studies show LSD's effects on the brain in full color

Hepatitis C has a cure — but many Americans still lack access to it

Clinic falsely told dozens they had Alzheimer's, suits say

explore

Why doctors need education on FDA device approval process

Francis Collins on trust in science and how Covid communications failed

Sophia Smith scores twice for US in in 3

Independent physicians launch a new lobbying group

PrEP can help anyone prevent HIV. Why do so few people take it?

PrEP can help anyone prevent HIV. Why do so few people take it?

explore

leisure time

hotspot

knowledge